<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Aspirantskiy Vestnik Povolzhiya</journal-id><journal-title-group><journal-title xml:lang="en">Aspirantskiy Vestnik Povolzhiya</journal-title><trans-title-group xml:lang="ru"><trans-title>Аспирантский вестник Поволжья</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2072-2354</issn><issn publication-format="electronic">2410-3764</issn><publisher><publisher-name xml:lang="en">Samara State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">24532</article-id><article-id pub-id-type="doi">10.17816/2072-2354.2014.0.1-2.139-141</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Identification of common factors osteopenic syndrome and arterial hypertension in teenagers</article-title><trans-title-group xml:lang="ru"><trans-title>Выявление общих факторов развития остеопенического синдрома и артериальной гипертензии у подростков</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Stadler</surname><given-names>E R</given-names></name><name xml:lang="ru"><surname>Стадлер</surname><given-names>Е Р</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Самарский государственный медицинский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2014-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2014</year></pub-date><volume>14</volume><issue>1-2</issue><issue-title xml:lang="en">NO1-2 (2014)</issue-title><issue-title xml:lang="ru">№1-2 (2014)</issue-title><fpage>139</fpage><lpage>141</lpage><history><date date-type="received" iso-8601-date="2020-03-11"><day>11</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2014, Stadler E.R.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2014, Стадлер Е.Р.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="en">Stadler E.R.</copyright-holder><copyright-holder xml:lang="ru">Стадлер Е.Р.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://aspvestnik.ru/2410-3764/article/view/24532">https://aspvestnik.ru/2410-3764/article/view/24532</self-uri><abstract xml:lang="en"><p>The paper analyzes the major risk factors of osteoporosis (OP), hypertension (AH) and atherosclerosis in adolescents aged 15-18 years. The study revealed a number of modifiable risk factors of atherosclerosis, hypertension and ETA. The analysis of the treatment of patients in both groups led to the conclusion that the appointment of adolescents with ETA calcium and vitamin D3 for 1 year contributed to the increase of the IPC.</p></abstract><trans-abstract xml:lang="ru"><p>В работе проводится анализ основных факторов риска развития остеопороза (ОП), артериальной гипертензии (АГ) с изменением липидного спектра у подростков в возрасте 15-18 лет. Проведенное исследование позволило выявить ряд модифицируемых факторов риска возникновения атеросклероза, АГ и ОП. Анализ терапии пациентов из обеих групп позволил сделать вывод, что назначение подросткам с ОП препаратов кальция и витамина D3 в течение 1 года способствовало увеличению минеральной плотности кости (МПК).</p></trans-abstract><kwd-group xml:lang="en"><kwd>osteopenic syndrome</kwd><kwd>hypertension</kwd><kwd>adolescence</kwd><kwd>calcium and phosphorus metabolism</kwd><kwd>bone metabolisme</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>остеопенический синдром</kwd><kwd>артериальная гипертензия</kwd><kwd>подростковый период</kwd><kwd>фосфорно-кальциевый обмен</kwd><kwd>костный метаболизм</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>McFarlane SI, Muniyappa R, Shin JJ, Bahitiyar G, Sowers JR. Osteoporosis and cardiovascular disease: brittle bones and boned arteries - is there a link? Endocrine 2004;23: 1-10.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Giachelli C.M., Bae N., Almeida M. et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaque. J Clin Invest 2003;92:1686-696.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Parhami F., Morrow A.D., Balucan J. et al. Li pid oxidation oroducts have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation of the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 2007;17:680-87.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Pahmani F., Garfinkel A., Demer L.L. Role of li pids in osteoporosis. Arterioscler Thromb Vasc Biol 2000;20:2346-2348.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Nishizava Y., Morii H. Osteoporosis and atherosclerosis in chronic renal failure. Osteoporosis Int 2004;7:Suppl 3:S188-192.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Stefenelli Т., Mayer H., Bergler-Klein J. et al. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 2003;95:197-202.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Woods А., Brull D.J., Humphries S.E., Montgomery H.E. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 2000;21:1574-583.</mixed-citation></ref></ref-list></back></article>
